The Forgotten Cure (Record no. 100815)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03434nam a22004575i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-4614-0251-0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220083238.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 111208s2012 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781461402510 |
| -- | 978-1-4614-0251-0 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-4614-0251-0 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | QR46 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MMFM |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED052000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.9041 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kuchment, Anna. |
| Relator term | author. |
| 245 14 - TITLE STATEMENT | |
| Title | The Forgotten Cure |
| Medium | [electronic resource] : |
| Remainder of title | The Past and Future of Phage Therapy / |
| Statement of responsibility, etc | by Anna Kuchment. |
| 264 #1 - | |
| -- | New York, NY : |
| -- | Springer New York, |
| -- | 2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XVI, 131p. 6 illus. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Prologue -- Helpful Little Bodies -- Inside Stalin's Empire -- The Fading of Phage Therapy -- Naked Genes -- They're Not a Panacea -- In Poland: Phages for Diabetes? -- The Renaissance of Phage Therapy -- The Startups -- Four Companies, Four Strategies -- Cows and Chickens -- Approval, At Last -- In Treatment -- Epilogue -- Index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | “Bacteriophages have the potential to stop many if not most life threatening, drug resistant bacterial infections. The Forgotten Cure is a non-stop, cover to cover read.” James D. Watson, Nobel Laureate “A lively tale of killer viruses, superbugs and a magical cure that has all the twists of a cold-war spy novel.” – George Hackett, Newsweek magazine “A marvelous, jargon-free historical account of the genesis, the ups-and-downs, and the current renaissance of phage therapy. The Forgotten Cure ranks at the level of Judson’s Eighth Day of Creation.” Sankar Adhya National Institutes of Health The Forgotten Cure: How a Long Lost Treatment Can Save Lives in the 21st Century Before the arrival of penicillin in the 1940s, phage therapy was one of the few weapons doctors had against bacterial infections. It saved the life of Hollywood legends Tom Mix and Elizabeth Taylor before being abandoned by Western science. Now, researchers and physicians are rediscovering the treatment, which pits phage viruses against their natural bacterial hosts, as a potential weapon against antibiotic-resistant infections. “The Forgotten Cure” traces the story of phages from Paris, where they were discovered in 1917; to Tbilisi, Georgia, where one of phage therapy’s earliest proponents died at the hands of Stalin; to the Nobel podium, where prominent scientists have been recognized for breakthroughs stemming from phage research. Today, a crop of biotech startups and dedicated physicians is racing to win regulatory approval for phage therapy before superbugs exhaust the last drug in the medical arsenal. Will they clear the hurdles in time? |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Immunology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical laboratories. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Microbiology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical Microbiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Laboratory Medicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Immunology. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781461402503 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-4614-0251-0 |
| 912 ## - | |
| -- | ZDB-2-SBL |
No items available.